1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide

C82H86F16N12O23S4 — CID 157418872

IUPAC1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide
SMILESO=C(NO)C1(S(=O)(=O)c2ccc(-c3ccc(OCCCC(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCN(C2CC2)CC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCCCC(F)(F)F)cn3)cc2)CCOCC1
InChIInChI=1S/C22H23F5N4O5S.C21H23F3N2O6S.C20H22F3N3O6S.C19H18F5N3O6S/c23-21(24,22(25,26)27)13-36-18-12-28-17(11-29-18)14-1-5-16(6-2-14)37(34,35)20(19(32)30-33)7-9-31(10-8-20)15-3-4-15;22-21(23,24)8-1-11-32-16-4-7-18(25-14-16)15-2-5-17(6-3-15)33(29,30)20(19(27)26-28)9-12-31-13-10-20;21-20(22,23)6-1-9-32-17-13-24-16(12-25-17)14-2-4-15(5-3-14)33(29,30)19(18(27)26-28)7-10-31-11-8-19;20-18(21,19(22,23)24)11-33-15-10-25-14(9-26-15)12-1-3-13(4-2-12)34(30,31)17(16(28)27-29)5-7-32-8-6-17/h1-2,5-6,11-12,15,33H,3-4,7-10,13H2,(H,30,32);2-7,14,28H,1,8-13H2,(H,26,27);2-5,12-13,28H,1,6-11H2,(H,26,27);1-4,9-10,29H,5-8,11H2,(H,27,28)
InChIKeyBPEDTHSWNBSECN-UHFFFAOYSA-N
MW2039.89 g/mol
LogP11.54
Rot. Bonds31

About 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide

1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide (PubChem CID 157418872) has the molecular formula C82H86F16N12O23S4 and a molecular weight of 2039.89 g/mol. Its IUPAC name is 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide.

Molecular Properties

Compound Name1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide
PubChem CID157418872
Molecular FormulaC82H86F16N12O23S4
Molecular Weight2039.89 g/mol
Exact Mass2038.46
IUPAC Name1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide
SMILESO=C(NO)C1(S(=O)(=O)c2ccc(-c3ccc(OCCCC(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCN(C2CC2)CC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCCCC(F)(F)F)cn3)cc2)CCOCC1
InChIInChI=1S/C22H23F5N4O5S.C21H23F3N2O6S.C20H22F3N3O6S.C19H18F5N3O6S/c23-21(24,22(25,26)27)13-36-18-12-28-17(11-29-18)14-1-5-16(6-2-14)37(34,35)20(19(32)30-33)7-9-31(10-8-20)15-3-4-15;22-21(23,24)8-1-11-32-16-4-7-18(25-14-16)15-2-5-17(6-3-15)33(29,30)20(19(27)26-28)9-12-31-13-10-20;21-20(22,23)6-1-9-32-17-13-24-16(12-25-17)14-2-4-15(5-3-14)33(29,30)19(18(27)26-28)7-10-31-11-8-19;20-18(21,19(22,23)24)11-33-15-10-25-14(9-26-15)12-1-3-13(4-2-12)34(30,31)17(16(28)27-29)5-7-32-8-6-17/h1-2,5-6,11-12,15,33H,3-4,7-10,13H2,(H,30,32);2-7,14,28H,1,8-13H2,(H,26,27);2-5,12-13,28H,1,6-11H2,(H,26,27);1-4,9-10,29H,5-8,11H2,(H,27,28)
InChIKeyBPEDTHSWNBSECN-UHFFFAOYSA-N
XLogP11.54
TPSA491.96 Ų
H-Bond Donors8
H-Bond Acceptors31
Rotatable Bonds31
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002039.89
LogP ≤ 511.54
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Perfluorinated_chain', 'substructure': 'N/A'}

Analyze 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide?
The IUPAC name of 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide (CID 157418872) is 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide.
What is the SMILES notation for 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide?
The canonical SMILES for 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide is O=C(NO)C1(S(=O)(=O)c2ccc(-c3ccc(OCCCC(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCN(C2CC2)CC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCC(F)(F)C(F)(F)F)cn3)cc2)CCOCC1.O=C(NO)C1(S(=O)(=O)c2ccc(-c3cnc(OCCCC(F)(F)F)cn3)cc2)CCOCC1.
What is the InChIKey of 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide?
The InChIKey is BPEDTHSWNBSECN-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H23F5N4O5S.C21H23F3N2O6S.C20H22F3N3O6S.C19H18F5N3O6S/c23-21(24,22(25,26)27)13-36-18-12-28-17(11-29-18)14-1-5-16(6-2-14)37(34,35)20(19(32)30-33)7-9-31(10-8-20)15-3-4-15;22-21(23,24)8-1-11-32-16-4-7-18(25-14-16)15-2-5-17(6-3-15)33(29,30)20(19(27)26-28)9-12-31-13-10-20;21-20(22,23)6-1-9-32-17-13-24-16(12-25-17)14-2-4-15(5-3-14)33(29,30)19(18(27)26-28)7-10-31-11-8-19;20-18(21,19(22,23)24)11-33-15-10-25-14(9-26-15)12-1-3-13(4-2-12)34(30,31)17(16(28)27-29)5-7-32-8-6-17/h1-2,5-6,11-12,15,33H,3-4,7-10,13H2,(H,30,32);2-7,14,28H,1,8-13H2,(H,26,27);2-5,12-13,28H,1,6-11H2,(H,26,27);1-4,9-10,29H,5-8,11H2,(H,27,28).
What are the key properties of 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide?
1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide has a molecular weight of 2039.89 g/mol, XLogP of 11.54, 31 rotatable bonds, 8 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclopropyl-N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonylpiperidine-4-carboxamide;N-hydroxy-4-[4-[5-(2,2,3,3,3-pentafluoropropoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)pyrazin-2-yl]phenyl]sulfonyloxane-4-carboxamide;N-hydroxy-4-[4-[5-(4,4,4-trifluorobutoxy)-2-pyridinyl]phenyl]sulfonyloxane-4-carboxamide is sourced from PubChem (CID 157418872), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).